Epileptic Seizures Treatment Market
- 2026 年市場規模
- USD 4.2 Bn
- 2033 年預估規模
- USD 6.1 Bn
- 年複合成長率 CAGR
- 5.6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Epileptic Seizures Treatment Market, By Drug Type (First Generation, Second Generation, Third Generation), By Seizure Type (Partial Seizures, Generalized Seizures, Unclassified Seizures), By Route of Administration (Oral/Buccal, Nasal, Rectal, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Epilepsy is a chronic disorder that causes unprovoked and recurrent seizures. A seizure is a sudden rush of electrical activity in the brain. Epilepsy is associated with disrupted activities in the brain called seizures, which affects the central nervous system. Epilepsy is categorized into generalized seizures and partial seizures based on the areas affected in the brain. An increasing number of epilepsy cases is expected to drive growth of the global epileptic seizures treatment market. For instance, according to the study by Epilepsy Action Australia statistics in 2017, around 50 million people globally had epilepsy with around 80% of the people living in emerging economies such as India, Brazil, and China.
Moreover, increasing launches of drugs for treatment of epilepsy is expected to create conducive environment for the market growth. For instance, in 2016, UCB Pharma Limited received the U.S. FDA approval for Briviact, for the treatment of patients with partial onset of seizures. Moreover, Mylan launched generic, Felbatol tablets for the treatment of epileptic seizures, in the U.S. after receiving approval from the U.S. Food & Drug Administration in 2016. These factors are expected to boost the market growth over the forecast period.
Market Dynamics
The increasing prevalence of epilepsy in adults and children, across the globe is expected to drive growth of the epileptic seizures treatment market during the forecast period. According to the WHO, around one-third of children with epilepsy can be assigned to a specific epilepsy syndrome, as defined by the most recently proposed system for organization of epilepsy syndrome. According to the Society of Neuroscience, in 2015, epilepsy affected around 10.5 million children worldwide, and the types and severity of the disorder varied significantly. Moreover, according to the American Academy of Pediatrics data published in April 2017, epilepsy affects 0.5% to 1% of children globally, and is the most frequently occurring chronic neurologic condition in childhood.
However, nonconventional anti-epileptic treatments and nonpharmacological approaches can potentially help in reduction of seizures or anti-epileptic drug toxicity. For instance, there has been increasing preference for alternative therapy for epilepsy such as corticosteroids, immunoglobulins, melatonin, and vitamins for treating children. Other than supplemental therapy, there are certain techniques that can help reduce epileptic seizures such as avoidance technique, which involves avoiding activities that can induce a seizure such as flickering lights, listening to specific type or piece of music, eating, reading, and immersion in hot water, chess playing, or brushing hair. Thus, these factors are expected to restrain the epileptic seizures treatment market growth. Other nonpharmacological treatments for epilepsy in children include herbal medicine, homeopathy, yoga, aromatherapy, and coping strategies.
Key features of the study
• This report provides in-depth analysis of the global epileptic seizures treatment market, market size (US$ Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026-2033, considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global epileptic seizures treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Novartis AG, GlaxoSmithKline Plc, Johnson & Johnson Service, Inc., Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Sanofi S.A., Mylan N.V., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., Abbott Laboratories, Sumitomo Dainippon Pharma Co., Ltd., GW Pharmaceuticals Plc, Marinus Pharmaceuticals, Inc., H. Lundbeck A/S, and Takeda Pharmaceutical Co., Ltd.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global epileptic seizures treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for epileptic seizures treatment market, research and consulting firms, new entrants, and financial analysts.
Market Segmentation
• By Drug Type Insights (Revenue, USD Bn, 2021 - 2033)
o First Generation
o Second Generation
o Third Generation
• By Seizure Type Insights (Revenue, USD Bn, 2021 - 2033)
o Partial Seizures
o Generalized Seizures
o Unclassified Seizures
• By Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
o Oral/Buccal
o Nasal
o Rectal
o Parenteral
• By Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region Insights (Revenue, USD Bn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players
o Novartis AG
o GlaxoSmithKline Plc
o Johnson & Johnson Service, Inc.
o Teva Pharmaceutical Industries Ltd.
o Pfizer, Inc.
o Sanofi S.A.
o Mylan N.V.
o Bausch Health Companies Inc.
o UCB S.A.
o Eisai Co. Ltd.
o Abbott Laboratories
o Sumitomo Dainippon Pharma Co., Ltd.
o GW Pharmaceuticals Plc
o Marinus Pharmaceuticals, Inc.
o Lundbeck A/S
o Takeda Pharmaceutical Co., Ltd
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Seizure Type
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Epidemiology
o Regulatory Scenario
o Reimbursement Scenario
o New Product Launches/Approvals
o Key Developments
o Government Initiatives and Funding
o Collaborations & Partnerships
o PEST Analysis
4. Global Epileptic Seizures Treatment Market, By Drug Type, 2021 – 2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o First Generation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Second Generation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Third Generation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
5. Global Epileptic Seizures Treatment Market, By Seizure Type, 2021 – 2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Partial Seizures
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Generalized Seizures
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Unclassified Seizures
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
6. Global Epileptic Seizures Treatment Market, By Route of Administration, 2021 – 2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Oral/Buccal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Nasal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Rectal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Parenteral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
7. Global Epileptic Seizures Treatment Market, By Distribution Channel, 2021 – 2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
8. Global Epileptic Seizures Treatment Market, By Region, 2021 – 2033, (US$ Billion)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, By Region, 2022 – 2033
Regional Trends
o North America
Market Size and Forecast, By Drug Type, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Seizure Type, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Country, 2021 – 2033, (US$ Billion)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Drug Type, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Seizure Type, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Country, 2021 – 2033, (US$ Billion)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Drug Type, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Seizure Type, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Country, 2021 – 2033, (US$ Billion)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Market Size and Forecast, By Drug Type, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Seizure Type, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Country, 2021 – 2033, (US$ Billion)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Middle East
Market Size and Forecast, By Drug Type, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Seizure Type, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Country, 2021 – 2033, (US$ Billion)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Drug Type, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Seizure Type, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Country/Region, 2021 – 2033, (US$ Billion)
o North Africa
o Central Africa
o South Africa
9. Competitive Landscape
o Company Profiles
Novartis AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
GlaxoSmithKline Plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Johnson & Johnson Service, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Teva Pharmaceutical Industries Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Pfizer, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Sanofi S.A.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Mylan N.V.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Bausch Health Companies Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
UCB S.A
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Eisai Co. Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Abbott Laboratories
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Sumitomo Dainippon Pharma Co., Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
GW Pharmaceuticals Plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Marinus Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Lundbeck A/S
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Takeda Pharmaceutical Co., Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
10. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們